To describe severity of emotional and physical symptoms in a large diverse sample; to examine demographic, health status, and behavioral correlates of symptom severity; and to describe use of medications and alternative remedies for premenstrual symptoms.
Methods
A total of 1194 women, ages 21-45, selected from members of a large northern California health maintenance organization, completed daily ratings of symptom severity for two menstrual cycles. An empirically derived algorithm defined symptom severity groups as minimal (n = 186), moderate (n = 801), severe (n = 151), or premenstrual dysphoric disorder (n = 56). Symptom severity as a continuous variable was defined by the two-cycle mean symptom ratings in the luteal phase. Demographic, health status, and behavioral factors and use of treatments for premenstrual symptoms were assessed by self-report.
Results
Luteal phase symptom-specific ratings were generally significantly greater in the premenstrual dysphoric disorder group than in the other groups (P <.001). Symptom severity score increased with each comorbidity and decreased with each year of age. Symptom severity was also inversely associated with oral contraceptive use (emotional symptoms) and better perceived health (physical symptoms). Hispanics reported greater severity of symptoms, and Asians less, relative to whites. Use of herbal and nutritional supplements for premenstrual symptoms steadily increased from 10.8% in the minimal group to 30.4% in the premenstrual dysphoric disorder group (P <.01).
Conclusion
The degree of premenstrual symptom severity varies in the population, is relatively constant within each woman over two consecutive cycles, particularly for emotional symptoms, and is influenced by age, race/ethnicity, and health status.
premenstrual symptom severity population-based HMO study, premenstrual dysphoric disorder daily symptom ratings luteal phase, PMS severity demographic correlates age race ethnicity, premenstrual symptoms herbal nutritional supplement use, PMDD prevalence severity community population women, Sternfeld premenstrual symptom severity health maintenance organization, oral contraceptive use premenstrual emotional symptom severity, premenstrual symptom algorithm minimal moderate severe PMDD classification, PMS comorbidity perceived health status symptom severity, daily prospective premenstrual symptom rating two menstrual cycles
PMID 12052592 12052592 DOI 10.1016/s0029-7844(02)01958-0 10.1016/s0029-7844(02)01958-0
Cite this article
Sternfeld, B., Swindle, R., Chawla, A., Long, S., & Kennedy, S. (2002). Severity of premenstrual symptoms in a health maintenance organization population. *Obstetrics and gynecology*, *99*(6), 1014-1024. https://doi.org/10.1016/s0029-7844(02)01958-0
Sternfeld B, Swindle R, Chawla A, Long S, Kennedy S. Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol. 2002;99(6):1014-1024. doi:10.1016/s0029-7844(02)01958-0
Sternfeld, Barbara, et al. "Severity of premenstrual symptoms in a health maintenance organization population." *Obstetrics and gynecology*, vol. 99, no. 6, 2002, pp. 1014-1024.
For many patients with endometriosis, laparoscopic surgery is the most effective treatment to alleviate severe chronic pelvic pain and improve quality of life. Because endometriosis is common among in...
Endometriosis > Surgery > Fertility OutcomesRRM Methods > Debate and Controversy > Endometriosis Surgery ClaimsEthics/Philosophy > Medical Ethics > Reproductive Treatment Access
Dahlke JD et al., 2020
Open Access
Obstetrics and Gynecology
In this Commentary, we explain the case for a standardized cesarean delivery surgical technique. There are three strong arguments for a standardized approach to cesarean delivery, the most common majo...
Perinatal palliative care refers to a coordinated care strategy that comprises options for obstetric and newborn care that include a focus on maximizing quality of life and comfort for newborns with a...
Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data regarding women with underlying medical conditions or other special circumsta...
Contraception/Comparison > Guidelines > Medical Eligibility CriteriaContraception/Comparison > Safety > Coexisting Medical ConditionsGeneral OB/GYN > Clinical Guidelines > ACOG Practice Bulletins